-
1
-
-
0037847545
-
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion
-
Abrahamyan, L. G., R. M. Markosyan, J. P. Moore, F. S. Cohen, and G. B. Melikyan. 2003. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. J. Virol. 77:5829-5836.
-
(2003)
J. Virol.
, vol.77
, pp. 5829-5836
-
-
Abrahamyan, L.G.1
Markosyan, R.M.2
Moore, J.P.3
Cohen, F.S.4
Melikyan, G.B.5
-
2
-
-
0023678874
-
Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines
-
Berman, P. W., W. M. Nunes, and O. K. Haffar. 1988. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines. J. Virol. 62:3135-3142.
-
(1988)
J. Virol.
, vol.62
, pp. 3135-3142
-
-
Berman, P.W.1
Nunes, W.M.2
Haffar, O.K.3
-
3
-
-
78651243915
-
Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum
-
Bhattacharyya, S., and T. J. Hope. 2011. Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol. J. 8:11.
-
(2011)
Virol. J.
, vol.8
, pp. 11
-
-
Bhattacharyya, S.1
Hope, T.J.2
-
4
-
-
77952001983
-
Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization
-
Binley, J., et al. 2010. Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J. Virol. 84:5637-5655.
-
(2010)
J. Virol.
, vol.84
, pp. 5637-5655
-
-
Binley, J.1
-
5
-
-
0038076112
-
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
-
Binley, J. M., et al. 2003. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J. Virol. 77:5678-5684.
-
(2003)
J. Virol.
, vol.77
, pp. 5678-5684
-
-
Binley, J.M.1
-
6
-
-
56449131391
-
Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasmas from subtype B and C chronic infections
-
Binley, J. M., et al. 2008. Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasmas from subtype B and C chronic infections. J. Virol. 82:11651-11668.
-
(2008)
J. Virol.
, vol.82
, pp. 11651-11668
-
-
Binley, J.M.1
-
7
-
-
0033985999
-
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
-
Binley, J. M., et al. 2000. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 74:627-643.
-
(2000)
J. Virol.
, vol.74
, pp. 627-643
-
-
Binley, J.M.1
-
8
-
-
0036184790
-
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins
-
Binley, J. M., et al. 2002. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 76:2606- 2616.
-
(2002)
J. Virol.
, vol.76
, pp. 2606-2616
-
-
Binley, J.M.1
-
9
-
-
8644251891
-
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
-
Binley, J. M., et al. 2004. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78:13232-13252.
-
(2004)
J. Virol.
, vol.78
, pp. 13232-13252
-
-
Binley, J.M.1
-
10
-
-
0025319347
-
Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site
-
Bosch, V., and M. Pawlita. 1990. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol. 64:2337-2344.
-
(1990)
J. Virol.
, vol.64
, pp. 2337-2344
-
-
Bosch, V.1
Pawlita, M.2
-
11
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
-
Burton, D. R., et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024- 1027.
-
(1994)
Science
, vol.266
, pp. 1024-1027
-
-
Burton, D.R.1
-
12
-
-
12444291017
-
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
-
Calarese, D. A., et al. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300:2065-2071.
-
(2003)
Science
, vol.300
, pp. 2065-2071
-
-
Calarese, D.A.1
-
13
-
-
0036317971
-
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface
-
Center, R. J., et al. 2002. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J. Virol. 76:7863- 7867.
-
(2002)
J. Virol.
, vol.76
, pp. 7863-7867
-
-
Center, R.J.1
-
14
-
-
20244369446
-
Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses
-
Chen, X., et al. 2005. Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses. J. Virol. 79:5537-5547.
-
(2005)
J. Virol.
, vol.79
, pp. 5537-5547
-
-
Chen, X.1
-
15
-
-
0036091692
-
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
-
Chertova, E., et al. 2002. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 76:5315-5325.
-
(2002)
J. Virol.
, vol.76
, pp. 5315-5325
-
-
Chertova, E.1
-
16
-
-
45049083040
-
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
-
Crooks, E. T., et al. 2008. Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization. Virology 377:364-378.
-
(2008)
Virology
, vol.377
, pp. 364-378
-
-
Crooks, E.T.1
-
17
-
-
34548577658
-
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
-
Crooks, E. T., et al. 2007. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 366:245-262.
-
(2007)
Virology
, vol.366
, pp. 245-262
-
-
Crooks, E.T.1
-
18
-
-
33646720281
-
Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization
-
Crooks, E. T., et al. 2005. Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum. Antibodies 14:101-113.
-
(2005)
Hum. Antibodies
, vol.14
, pp. 101-113
-
-
Crooks, E.T.1
-
19
-
-
7244232761
-
Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry
-
Cutalo, J. M., L. J. Deterding, and K. B. Tomer. 2004. Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J. Am. Soc. Mass Spectrom. 15:1545-1555.
-
(2004)
J. Am. Soc. Mass Spectrom.
, vol.15
, pp. 1545-1555
-
-
Cutalo, J.M.1
Deterding, L.J.2
Tomer, K.B.3
-
20
-
-
0024334165
-
Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport
-
Dewar, R. L., M. B. Vasudevachari, V. Natarajan, and N. P. Salzman. 1989. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. J. Virol. 63:2452-2456.
-
(1989)
J. Virol.
, vol.63
, pp. 2452-2456
-
-
Dewar, R.L.1
Vasudevachari, M.B.2
Natarajan, V.3
Salzman, N.P.4
-
21
-
-
77956385205
-
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
-
Doores, K. J., et al. 2010. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc. Natl. Acad. Sci. U. S. A. 107: 13800-13805.
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 13800-13805
-
-
Doores, K.J.1
-
22
-
-
0025095635
-
Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein
-
Earl, P. L., R. W. Doms, and B. Moss. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 87:648-652.
-
(1990)
Proc. Natl. Acad. Sci. U. S. A.
, vol.87
, pp. 648-652
-
-
Earl, P.L.1
Doms, R.W.2
Moss, B.3
-
23
-
-
0026029621
-
Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein
-
Earl, P. L., B. Moss, and R. W. Doms. 1991. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 65:2047-2055.
-
(1991)
J. Virol.
, vol.65
, pp. 2047-2055
-
-
Earl, P.L.1
Moss, B.2
Doms, R.W.3
-
24
-
-
77951988965
-
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function
-
Eggink, D., et al. 2010. Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. Virology 401:236-247.
-
(2010)
Virology
, vol.401
, pp. 236-247
-
-
Eggink, D.1
-
25
-
-
0026577244
-
Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage
-
Fenouillet, E., and J. C. Gluckman. 1992. Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage. Virology 187:825-828.
-
(1992)
Virology
, vol.187
, pp. 825-828
-
-
Fenouillet, E.1
Gluckman, J.C.2
-
26
-
-
0029925311
-
Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines
-
Fenouillet, E., R. Miquelis, and R. Drillien. 1996. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Virology 218:224-231.
-
(1996)
Virology
, vol.218
, pp. 224-231
-
-
Fenouillet, E.1
Miquelis, R.2
Drillien, R.3
-
27
-
-
69549103041
-
Fc receptor-mediated antiviral antibodies
-
Forthal, D. N., and C. Moog. 2009. Fc receptor-mediated antiviral antibodies. Curr. Opin. HIV AIDS 4:388-393.
-
(2009)
Curr. Opin. HIV AIDS
, vol.4
, pp. 388-393
-
-
Forthal, D.N.1
Moog, C.2
-
28
-
-
0030897825
-
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
-
Fouts, T. R., J. M. Binley, A. Trkola, J. E. Robinson, and J. P. Moore. 1997. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71:2779- 2785.
-
(1997)
J. Virol.
, vol.71
, pp. 2779-2785
-
-
Fouts, T.R.1
Binley, J.M.2
Trkola, A.3
Robinson, J.E.4
Moore, J.P.5
-
29
-
-
29444442970
-
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
-
Frost, S. D., et al. 2005. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U. S. A. 102:18514-18519.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 18514-18519
-
-
Frost, S.D.1
-
30
-
-
0032763888
-
Evolutionary considerations in relating oligosaccharide diversity to biological function
-
Gagneux, P., and A. Varki. 1999. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9:747-755.
-
(1999)
Glycobiology
, vol.9
, pp. 747-755
-
-
Gagneux, P.1
Varki, A.2
-
31
-
-
0023811767
-
Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120
-
Geyer, H., C. Holschbach, G. Hunsmann, and J. Schneider. 1988. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 263:11760-11767.
-
(1988)
J. Biol. Chem.
, vol.263
, pp. 11760-11767
-
-
Geyer, H.1
Holschbach, C.2
Hunsmann, G.3
Schneider, J.4
-
32
-
-
45549101708
-
Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility
-
Go, E. P., et al. 2008. Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J. Proteome Res. 7:1660-1674.
-
(2008)
J. Proteome Res.
, vol.7
, pp. 1660-1674
-
-
Go, E.P.1
-
33
-
-
34648816125
-
N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization
-
Gray, E. S., P. L. Moore, R. A. Pantophlet, and L. Morris. 2007. N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization. J. Virol. 81:10769-10776.
-
(2007)
J. Virol.
, vol.81
, pp. 10769-10776
-
-
Gray, E.S.1
Moore, P.L.2
Pantophlet, R.A.3
Morris, L.4
-
34
-
-
27744503475
-
Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization
-
Hammonds, J., et al. 2005. Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization. J. Virol. 79:14804-14814.
-
(2005)
J. Virol.
, vol.79
, pp. 14804-14814
-
-
Hammonds, J.1
-
35
-
-
33746763724
-
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
-
Haynes, B. F., and D. C. Montefiori. 2006. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev. Vaccines 5:347-363.
-
(2006)
Expert Rev. Vaccines
, vol.5
, pp. 347-363
-
-
Haynes, B.F.1
Montefiori, D.C.2
-
36
-
-
77954110431
-
Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
-
Hioe, C. E., et al. 2010. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes. PLoS One 5:e10254.
-
(2010)
PLoS One
, vol.5
-
-
Hioe, C.E.1
-
37
-
-
67650741139
-
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
-
Kang, Y. K., et al. 2009. Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine 27:5120- 5132.
-
(2009)
Vaccine
, vol.27
, pp. 5120-5132
-
-
Kang, Y.K.1
-
38
-
-
0023678264
-
Improved antigenicity of the HIV env protein by cleavage site removal
-
Kieny, M. P., et al. 1988. Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng. 2:219-225.
-
(1988)
Protein Eng
, vol.2
, pp. 219-225
-
-
Kieny, M.P.1
-
39
-
-
0021891884
-
Assembly of asparagine-linked oligosaccharides
-
Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:631-664.
-
(1985)
Annu. Rev. Biochem.
, vol.54
, pp. 631-664
-
-
Kornfeld, R.1
Kornfeld, S.2
-
40
-
-
0033555453
-
Fusion-competent vaccines: broad neutralization of primary isolates of HIV
-
LaCasse, R. A., et al. 1999. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science 283:357-362.
-
(1999)
Science
, vol.283
, pp. 357-362
-
-
LaCasse, R.A.1
-
41
-
-
0038725418
-
Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage
-
Land, A., D. Zonneveld, and I. Braakman. 2003. Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage. FASEB J. 17:1058-1067.
-
(2003)
FASEB J
, vol.17
, pp. 1058-1067
-
-
Land, A.1
Zonneveld, D.2
Braakman, I.3
-
42
-
-
33947712049
-
Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference
-
Larke, N., et al. 2007. Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference. Eur. J. Immunol. 37:566-577.
-
(2007)
Eur. J. Immunol.
, vol.37
, pp. 566-577
-
-
Larke, N.1
-
43
-
-
77949378988
-
In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1
-
Leaman, D. P., H. Kinkead, and M. B. Zwick. 2010. In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1. J. Virol. 84:3382-3395.
-
(2010)
J. Virol.
, vol.84
, pp. 3382-3395
-
-
Leaman, D.P.1
Kinkead, H.2
Zwick, M.B.3
-
44
-
-
23244434512
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccineelicited neutralizing antibodies
-
Li, M., et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccineelicited neutralizing antibodies. J. Virol. 79:10108-10125.
-
(2005)
J. Virol.
, vol.79
, pp. 10108-10125
-
-
Li, M.1
-
45
-
-
33751224478
-
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa
-
Li, M., et al. 2006. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 80:11776- 11790.
-
(2006)
J. Virol.
, vol.80
, pp. 11776-11790
-
-
Li, M.1
-
46
-
-
0029792920
-
Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport
-
Li, Y., et al. 1996. Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. Proc. Natl. Acad. Sci. U. S. A. 93:9606-9611.
-
(1996)
Proc. Natl. Acad. Sci. U. S. A.
, vol.93
, pp. 9606-9611
-
-
Li, Y.1
-
47
-
-
0027535672
-
Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
-
Li, Y., L. Luo, N. Rasool, and C. Y. Kang. 1993. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J. Virol. 67:584-588.
-
(1993)
J. Virol.
, vol.67
, pp. 584-588
-
-
Li, Y.1
Luo, L.2
Rasool, N.3
Kang, C.Y.4
-
48
-
-
0034608884
-
The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding
-
Li, Y., L. Luo, D. Y. Thomas, and C. Y. Kang. 2000. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Virology 272:417-428.
-
(2000)
Virology
, vol.272
, pp. 417-428
-
-
Li, Y.1
Luo, L.2
Thomas, D.Y.3
Kang, C.Y.4
-
49
-
-
1942517392
-
Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion
-
Ling, H., P. Xiao, O. Usami, and T. Hattori. 2004. Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion. Microbes Infect. 6:414-420.
-
(2004)
Microbes Infect
, vol.6
, pp. 414-420
-
-
Ling, H.1
Xiao, P.2
Usami, O.3
Hattori, T.4
-
50
-
-
0023921610
-
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
-
McCune, J. M., et al. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53:55-67.
-
(1988)
Cell
, vol.53
, pp. 55-67
-
-
McCune, J.M.1
-
51
-
-
0034469405
-
Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases
-
Means, R. E., and R. C. Desrosiers. 2000. Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J. Virol. 74:11181-11190.
-
(2000)
J. Virol.
, vol.74
, pp. 11181-11190
-
-
Means, R.E.1
Desrosiers, R.C.2
-
52
-
-
78449235077
-
Induction of cytopathic effects and apoptosis in Spodoptera frugiperda cells by the HIV-1 Env glycoprotein signal peptide
-
Michalski, C. J., Y. Li, and C. Y. Kang. 2010. Induction of cytopathic effects and apoptosis in Spodoptera frugiperda cells by the HIV-1 Env glycoprotein signal peptide. Virus Genes 41:341-350.
-
(2010)
Virus Genes
, vol.41
, pp. 341-350
-
-
Michalski, C.J.1
Li, Y.2
Kang, C.Y.3
-
53
-
-
0025374887
-
Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues
-
Mizuochi, T., et al. 1990. Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem. 265:8519-8524.
-
(1990)
J. Biol. Chem.
, vol.265
, pp. 8519-8524
-
-
Mizuochi, T.1
-
54
-
-
0025572710
-
Dissociation of gp120 from HIV-1 virions induced by soluble CD4
-
Moore, J., J. McKeating, R. Weiss, and Q. Sattentau. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139-1142.
-
(1990)
Science
, vol.250
, pp. 1139-1142
-
-
Moore, J.1
McKeating, J.2
Weiss, R.3
Sattentau, Q.4
-
55
-
-
33144486096
-
Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
-
Moore, P. L., et al. 2006. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 80:2515-2528.
-
(2006)
J. Virol.
, vol.80
, pp. 2515-2528
-
-
Moore, P.L.1
-
56
-
-
34247106331
-
An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10
-
Nelson, J. D., et al. 2007. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J. Virol. 81:4033-4043.
-
(2007)
J. Virol.
, vol.81
, pp. 4033-4043
-
-
Nelson, J.D.1
-
57
-
-
0031710046
-
Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1
-
Nyambi, P. N., et al. 1998. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J. Virol. 72:9384-9391.
-
(1998)
J. Virol.
, vol.72
, pp. 9384-9391
-
-
Nyambi, P.N.1
-
58
-
-
34250027638
-
Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis
-
Pantophlet, R., R. O. Aguilar-Sino, T. Wrin, L. A. Cavacini, and D. R. Burton. 2007. Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology 364:441-453.
-
(2007)
Virology
, vol.364
, pp. 441-453
-
-
Pantophlet, R.1
Aguilar-Sino, R.O.2
Wrin, T.3
Cavacini, L.A.4
Burton, D.R.5
-
59
-
-
34347256384
-
Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets
-
Phogat, S., R. T. Wyatt, and G. B. Karlsson Hedestam. 2007. Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets. J. Intern. Med. 262:26-43.
-
(2007)
J. Intern. Med.
, vol.262
, pp. 26-43
-
-
Phogat, S.1
Wyatt, R.T.2
Karlsson Hedestam, G.B.3
-
60
-
-
0037213278
-
Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
-
Poignard, P., et al. 2003. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. J. Virol. 77:353-365.
-
(2003)
J. Virol.
, vol.77
, pp. 353-365
-
-
Poignard, P.1
-
61
-
-
20144388317
-
Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1
-
Poon, B., et al. 2005. Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1. J. Virol. 79:4927-4935.
-
(2005)
J. Virol.
, vol.79
, pp. 4927-4935
-
-
Poon, B.1
-
62
-
-
69249216589
-
The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity
-
Provine, N. M., W. B. Puryear, X. Wu, J. Overbaugh, and N. L. Haigwood. 2009. The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity. J. Virol. 83:9002-9007.
-
(2009)
J. Virol.
, vol.83
, pp. 9002-9007
-
-
Provine, N.M.1
Puryear, W.B.2
Wu, X.3
Overbaugh, J.4
Haigwood, N.L.5
-
63
-
-
73349094086
-
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
-
Rerks-Ngarm, S., et al. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361:2209-2220.
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 2209-2220
-
-
Rerks-Ngarm, S.1
-
64
-
-
0036637385
-
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
-
Sanders, R. W., et al. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
-
(2002)
J. Virol.
, vol.76
, pp. 7293-7305
-
-
Sanders, R.W.1
-
65
-
-
0036333661
-
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
-
Sanders, R. W., et al. 2002. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J. Virol. 76:8875-8889.
-
(2002)
J. Virol.
, vol.76
, pp. 8875-8889
-
-
Sanders, R.W.1
-
66
-
-
18244422922
-
The broadly neutralizing anti-human immuno-deficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
-
Scanlan, C. N., et al. 2002. The broadly neutralizing anti-human immuno-deficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
-
(2002)
J. Virol.
, vol.76
, pp. 7306-7321
-
-
Scanlan, C.N.1
-
67
-
-
34547804722
-
Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody
-
Scanlan, C. N., et al. 2007. Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. J. Mol. Biol. 372:16-22.
-
(2007)
J. Mol. Biol.
, vol.372
, pp. 16-22
-
-
Scanlan, C.N.1
-
69
-
-
0036315133
-
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein
-
Schulke, N., et al. 2002. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein. J. Virol. 76:7760-7776.
-
(2002)
J. Virol.
, vol.76
, pp. 7760-7776
-
-
Schulke, N.1
-
70
-
-
0020035202
-
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion
-
Skehel, J. J., et al. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 79:968-972.
-
(1982)
Proc. Natl. Acad. Sci. U. S. A.
, vol.79
, pp. 968-972
-
-
Skehel, J.J.1
-
71
-
-
0025266354
-
Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex
-
Stein, B. S., and E. G. Engleman. 1990. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J. Biol. Chem. 265:2640-2649.
-
(1990)
J. Biol. Chem.
, vol.265
, pp. 2640-2649
-
-
Stein, B.S.1
Engleman, E.G.2
-
72
-
-
0036791359
-
Furin at the cutting edge: from protein traffic to embryogenesis and disease
-
Thomas, G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3:753-766.
-
(2002)
Nat. Rev. Mol. Cell Biol.
, vol.3
, pp. 753-766
-
-
Thomas, G.1
-
73
-
-
55549118890
-
Deceptive imprinting and immune refocusing in vaccine design
-
Tobin, G. J., et al. 2008. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26:6189-6199.
-
(2008)
Vaccine
, vol.26
, pp. 6189-6199
-
-
Tobin, G.J.1
-
74
-
-
57349127300
-
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia
-
Tomaras, G. D., et al. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
-
(2008)
J. Virol.
, vol.82
, pp. 12449-12463
-
-
Tomaras, G.D.1
-
75
-
-
9044241681
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
-
Trkola, A., et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
-
(1996)
J. Virol.
, vol.70
, pp. 1100-1108
-
-
Trkola, A.1
-
76
-
-
34250904229
-
The nature and consequences of intra- and inter-vaccine interference
-
Vidor, E. 2007. The nature and consequences of intra- and inter-vaccine interference. J. Comp. Pathol. 137(Suppl. 1):S62-S66.
-
(2007)
J. Comp. Pathol.
, vol.137
, Issue.SUPPL. 1
-
-
Vidor, E.1
-
77
-
-
0032853685
-
Immunogenicity of full-length and truncated SIV envelope proteins
-
Vzorov, A. N., D. Lea-Fox, and R. W. Compans. 1999. Immunogenicity of full-length and truncated SIV envelope proteins. Viral Immunol. 12:205- 215.
-
(1999)
Viral Immunol
, vol.12
, pp. 205-215
-
-
Vzorov, A.N.1
Lea-Fox, D.2
Compans, R.W.3
-
78
-
-
77953543379
-
Rational antibody-based HIV-1 vaccine design: current approaches and future directions
-
Walker, L. M., and D. R. Burton. 2010. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr. Opin. Immunol. 22:358-366.
-
(2010)
Curr. Opin. Immunol.
, vol.22
, pp. 358-366
-
-
Walker, L.M.1
Burton, D.R.2
-
79
-
-
78349278899
-
The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy
-
Wang, X., et al. 2010. The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy. Parasit. Vectors 3:109.
-
(2010)
Parasit. Vectors
, vol.3
, pp. 109
-
-
Wang, X.1
-
80
-
-
0010296944
-
Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160
-
Willey, R. L., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. U. S. A. 85:9580-9584.
-
(1988)
Proc. Natl. Acad. Sci. U. S. A.
, vol.85
, pp. 9580-9584
-
-
Willey, R.L.1
Bonifacino, J.S.2
Potts, B.J.3
Martin, M.A.4
Klausner, R.D.5
-
81
-
-
0025813326
-
Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing
-
Willey, R. L., T. Klimkait, D. M. Frucht, J. S. Bonifacino, and M. A. Martin. 1991. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology 184:319-329.
-
(1991)
Virology
, vol.184
, pp. 319-329
-
-
Willey, R.L.1
Klimkait, T.2
Frucht, D.M.3
Bonifacino, J.S.4
Martin, M.A.5
-
82
-
-
77954920017
-
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
-
Wu, X., et al. 2010. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329:856-861.
-
(2010)
Science
, vol.329
, pp. 856-861
-
-
Wu, X.1
-
83
-
-
0036436313
-
Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies
-
Xiang, S. H., N. Doka, R. K. Choudhary, J. Sodroski, and J. E. Robinson. 2002. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res. Hum. Retroviruses 18:1207-1217.
-
(2002)
AIDS Res. Hum. Retroviruses
, vol.18
, pp. 1207-1217
-
-
Xiang, S.H.1
Doka, N.2
Choudhary, R.K.3
Sodroski, J.4
Robinson, J.E.5
-
84
-
-
0034687168
-
Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells
-
Zhu, X., C. Borchers, R. J. Bienstock, and K. B. Tomer. 2000. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39:11194-11204.
-
(2000)
Biochemistry
, vol.39
, pp. 11194-11204
-
-
Zhu, X.1
Borchers, C.2
Bienstock, R.J.3
Tomer, K.B.4
|